Your browser doesn't support javascript.
loading
Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics.
Stern, Esther; Caruso, Stefano; Meiller, Clément; Mishalian, Inbal; Hirsch, Theo Z; Bayard, Quentin; Tadmor, Carmit T; Wald, Hanna; Jean, Didier; Wald, Ori.
Afiliación
  • Stern E; Gene Therapy Institute, Hadassah Hebrew University Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Caruso S; Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université Paris Cité, team Functional Genomics of Solid Tumors, Paris, France.
  • Meiller C; Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université Paris Cité, team Functional Genomics of Solid Tumors, Paris, France.
  • Mishalian I; Gene Therapy Institute, Hadassah Hebrew University Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Hirsch TZ; Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université Paris Cité, team Functional Genomics of Solid Tumors, Paris, France.
  • Bayard Q; Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université Paris Cité, team Functional Genomics of Solid Tumors, Paris, France.
  • Tadmor CT; Gene Therapy Institute, Hadassah Hebrew University Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Wald H; Tel Aviv University, Tel Aviv, Israel.
  • Jean D; Gene Therapy Institute, Hadassah Hebrew University Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Wald O; Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université Paris Cité, team Functional Genomics of Solid Tumors, Paris, France.
Front Immunol ; 13: 1026185, 2022.
Article en En | MEDLINE | ID: mdl-36685577

Texto completo: 1 Colección: 01-internacional Asunto principal: Mesotelioma Maligno / Mesotelioma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Colección: 01-internacional Asunto principal: Mesotelioma Maligno / Mesotelioma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Israel